Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 28;14(21):4555.
doi: 10.3390/nu14214555.

The Role of Individually Selected Diets in Obese Women with PCOS-A Review

Affiliations
Review

The Role of Individually Selected Diets in Obese Women with PCOS-A Review

Izabela Chudzicka-Strugała et al. Nutrients. .

Abstract

Polycystic ovarian syndrome (PCOS) is one of the most common heterogeneous endocrine and metabolic disorders in premenopausal women. It is a complex multifactorial disorder with strong epigenetic and environmental influences, including factors related to eating habits and lifestyle. There is a close relationship between obesity and PCOS. Weight gain and obesity are often clinical symptoms manifested by biochemical markers. Moreover, abdominal obesity in women with PCOS is involved in the development of inflammatory changes. A significant share of balanced therapies correcting the lifestyle of patients is suggested, e.g., with the implementation of appropriate diets to minimize exposure to inflammatory factors and prevent abnormal immune system stimulation. In the case of obese patients with PCOS, planning a diet program and supporting the motivation to change eating habits play an important role to lose weight and lower BMI. Probiotics/synbiotic supplementation may enhance weight loss during the diet program and additionally positively affect metabolic and inflammatory factors by improving the intestinal microbiome.

Keywords: diet; obesity/overweight; polycystic ovary syndrome; probiotics/synbiotic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Wolf W.M., Wattick R.A., Kinkade O.N., Olfert M.D. The Current Description and Future Need for Multidisciplinary PCOS Clinics. J. Clin. Med. 2018;7:395. doi: 10.3390/jcm7110395. - DOI - PMC - PubMed
    1. Liu R., Zhang C., Shi Y., Zhang F., Li L., Wang X., Ling Y., Fu H., Dong W., Shen J. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front. Microbiol. 2017;8:324. doi: 10.3389/fmicb.2017.00324. - DOI - PMC - PubMed
    1. Barber T.M., Hanson P., Weickert M.O., Franks S. Obesity and polycystic ovary syndrome: Implications for pathogenesis and novel management strategies. Clin. Med. Insights Reprod. Health. 2019;13:1179558119874042. doi: 10.1177/1179558119874042. - DOI - PMC - PubMed
    1. Ng N.Y.H., Jiang G., Cheung L.P., Zhang Y., Tam C.H.T., Luk A.O.Y., Quan J., Lau E.S.H., Yau T.T.L., Chan M.H.M. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study. PLoS Med. 2019;16:e1002953. doi: 10.1371/journal.pmed.1002953. - DOI - PMC - PubMed
    1. González F. Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77:300–305. doi: 10.1016/j.steroids.2011.12.003. - DOI - PMC - PubMed